MeDex: No Perioperative Dexamethasone in Brain Metastases
ConditionBrain Metastases
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Louisville
About this trial
Perioperative treatment of newly diagnosed cancer patients with brain metastasis without dexamethasone (Dex).
Eligibility criteria
Qualifiers
New brain tumor(s) on imaging
Visceral mass(es) suspicious or confirmed for neoplasm
No contraindications for craniotomy
Age ≥ 18 years
Disqualifiers
Presence of BMs not eligible for resection that are each > 2 cm in any one dimension
>4 BMs not eligible for resection that are each 2 cm in any one dimension
Treatment with laser interstitial thermal therapy (LITT)
High concern for primary CNS lymphoma
Trial design
Treatments tested in this trial
- Withholding perioperative Dexamethasone
Treatment groups
35 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov